DAVA Oncology
Ameya Pawar is a seasoned professional in the oncology and medical research fields, currently serving as a Business Development Associate at DAVA Oncology since November 2021, where responsibilities include prospecting new customers with effective strategies. Previously, Ameya held the position of Research Analyst at DAVA Oncology, focusing on enhancing knowledge dissemination in cancer treatment through various research tools and publications. Prior experience includes working as a Molecular Biologist at HINDLABS, diagnosing infectious diseases, and as a Research Assistant at the University of Pune, where Ameya established the prevalence of haemoglobinopathies. Ameya Pawar holds a Master's degree in Oncology and Cancer Biology from Kingston University and a Master's degree in Microbiology from Savitribai Phule Pune University, along with a Bachelor's degree in Industrial Microbiology from the same institution. Educational background also includes ISC and ICSE qualifications from The Bishops School and St. Helena's School, respectively.
This person is not in any offices
DAVA Oncology
DAVA Oncology was founded in 2007 with the goal of facilitating successful cancer drug development by providing innovative solutions and services to the pharmaceutical and biotechnology industries. DAVA has three business units - DAVA Clinical Trial Acceleration Services, Oncology Meeting Innovations and ONE Oncology. These business units accelerate clinical trial research timelines through MD-to-MD focused trial education, host non-CME scientific exchange programs across more than fifteen solid tumor and hematologic malignancies and create both custom and syndicated oncology education tools, respectively.